{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:20:16Z","timestamp":1781184016381,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1100522"],"award-info":[{"award-number":["G1100522"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L022508\/1"],"award-info":[{"award-number":["MR\/L022508\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.pt.2022.08.005","type":"journal-article","created":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T08:09:01Z","timestamp":1662192541000},"page":"933-941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["WHO antimalarial trial guidelines: good science, bad news?"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1332-742X","authenticated-orcid":false,"given":"Ian M.","family":"Hastings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1255-2606","authenticated-orcid":false,"given":"Ingrid","family":"Felger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2022.08.005_bb0005","series-title":"Methods for Surveillance of Antimalarial Drug Efficacy","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.pt.2022.08.005_bb0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4269\/ajtmh.1997.56.436","article-title":"Evidence that recurrent Plasmodium falciparum infection is caused by recrudescence of resistant parasites","volume":"56","author":"Al-Yaman","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2022.08.005_bb0015","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1365-3156.1998.00253.x","article-title":"Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children","volume":"3","author":"Irion","year":"1998","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.pt.2022.08.005_bb0020","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0169-4758(98)01340-4","article-title":"The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment","volume":"14","author":"Snounou","year":"1998","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.pt.2022.08.005_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pt.2009.12.007","article-title":"The perils of PCR: can we accurately 'correct' antimalarial trials?","volume":"26","author":"Juliano","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2022.08.005_bb0030","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S1473-3099(19)30426-8","article-title":"PCR correction strategies for malaria drug trials: updates and clarifications","volume":"20","author":"Felger","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2022.08.005_bb0035","series-title":"Informal Consultation on Methodology to Distinguish Reinfection from Recrudescence in High Malaria Transmission Areas","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.pt.2022.08.005_bb0040","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","article-title":"Antimalarial drug resistance in Africa: the calm before the storm?","volume":"19","author":"Conrad","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2022.08.005_bb0045","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2022.08.005_bb0050","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2022.08.005_bb0055","series-title":"Methods and Techniques for Clinical Trials on Antimalarial Drug Efficacy: Genotyping to Identify Parasite Populations","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.pt.2022.08.005_bb0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/510910","article-title":"Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania","volume":"195","author":"Martensson","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2022.08.005_bb0065","doi-asserted-by":"crossref","first-page":"e01500","DOI":"10.1128\/AAC.01500-16","article-title":"Critical evaluation of molecular monitoring in malaria drug efficacy trials and pitfalls of length-polymorphic markers","volume":"61","author":"Messerli","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2022.08.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00590-19","article-title":"Improving methods for analysing anti-malarial drug efficacy trials: molecular correction based on length-polymorphic markers msp-1, msp-2 and glurp","volume":"63","author":"Jones","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2022.08.005_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00437-21","article-title":"Should deep-sequenced amplicons become the new gold-standard for analysing malaria drug clinical trials?","volume":"65","author":"Jones","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2022.08.005_bb0080","doi-asserted-by":"crossref","first-page":"e01517","DOI":"10.1128\/AAC.01517-19","article-title":"A computer modelling approach to evaluate the accuracy of microsatellite markers for classification of recurrent infections during routine monitoring of antimalarial drug efficacy","volume":"64","author":"Jones","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2022.08.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00072-15","article-title":"Robust algorithm for systematic classification of malaria late treatment failures as recrudescence or reinfection using microsatellite genotyping","volume":"59","author":"Plucinski","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2022.08.005_bb0090","doi-asserted-by":"crossref","first-page":"836","DOI":"10.4269\/ajtmh.2006.75.836","article-title":"Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections","volume":"75","author":"Greenhouse","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2022.08.005_bb0095","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1038\/s41598-019-39656-7","article-title":"Longitudinal tracking and quantification of individual Plasmodium falciparum clones in complex infections","volume":"9","author":"Lerch","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2022.08.005_bb0100","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1186\/s12864-017-4260-y","article-title":"Development of amplicon deep sequencing markers and data analysis pipeline for genotyping multi-clonal malaria infections","volume":"18","author":"Lerch","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.pt.2022.08.005_bb0105","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12936-017-2137-9","article-title":"A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and explore apical membrane antigen 1 diversity","volume":"16","author":"Miller","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2022.08.005_bb0110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12936-019-2856-1","article-title":"Detection of low-density Plasmodium falciparum infections using amplicon deep sequencing","volume":"18","author":"Early","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2022.08.005_bb0115","doi-asserted-by":"crossref","first-page":"20138","DOI":"10.1073\/pnas.1007068107","article-title":"Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing","volume":"107","author":"Juliano","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2022.08.005_bb0120","doi-asserted-by":"crossref","first-page":"17790","DOI":"10.1038\/s41598-019-54203-0","article-title":"Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs","volume":"9","author":"Gruenberg","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2022.08.005_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(03)15330-5","article-title":"WHO, the Global Fund, and medical malpractice in malaria treatment","volume":"363","author":"Attaran","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2022.08.005_bb0130","series-title":"WHO Guidelines for Malaria","author":"World Health Organisation","year":"2022"},{"key":"10.1016\/j.pt.2022.08.005_bb0135","series-title":"Guidelines for the TReatment of Malaria","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.pt.2022.08.005_bb0140","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1473-3099(07)70214-1","article-title":"The anatomy of a malaria disaster: drug policy choice and mortality in African children","volume":"7","author":"Hastings","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2022.08.005_bb0145","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1128\/AAC.00159-07","article-title":"Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials","volume":"51","author":"Greenhouse","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2022.08.005_bb0150","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.4269\/ajtmh.20-1481","article-title":"Variation in calculating and reporting antimalarial efficacy against Plasmodium falciparum in sub-Saharan Africa \u2013 a systematic review of published reports","volume":"104","author":"Plucinski","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2022.08.005_bb0155","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12936-017-1712-4","article-title":"Efficacy of artemether\u2013lumefantrine, artesunate\u2013amodiaquine, and dihydroartemisinin\u2013piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015","volume":"16","author":"Plucinski","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2022.08.005_bb0160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/AAC.04181-14","article-title":"Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and U\u00edge Provinces, Angola","volume":"59","author":"Plucinski","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2022.08.005_bb0165","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4269\/ajtmh.21-0214","article-title":"Therapeutic efficacy of artemisinin-based combination therapies in Democratic Republic of the Congo and investigation of molecular markers of antimalarial resistance","volume":"105","author":"Moriarty","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2022.08.005_bb0170","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12936-021-04021-5","article-title":"Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda","volume":"20","author":"Ebong","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2022.08.005_bb0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12936-020-03290-w","article-title":"Efficacy and safety of artesunate-amodiaquine and artemether-lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial","volume":"19","author":"Beavogui","year":"2020","journal-title":"Malar. J."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492222001829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492222001829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:38:59Z","timestamp":1761464339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492222001829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1471492222001829"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2022.08.005","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WHO antimalarial trial guidelines: good science, bad news?","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2022.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}